Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Metrics Regulatory News (OMG)

Share Price Information for Oxford Metrics (OMG)

Share Price is delayed by 15 minutes
Get Live Data
46.00    -2.00 (-4.17%)
Bid:
46.10
Ask:
47.90
Spread: 1.80 (3.905%)
Market Cap: £51.49m
OMG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Metrics Share Chart

Director Dealing

18 Dec 2015 12:45

RNS Number : 5976J
OMG PLC
18 December 2015
 

OMG plc

 

("OMG" or the "Group")

 

Director Dealing

 

OMG plc (LSE: OMG), the technology group providing Computer Vision products and services for the entertainment, life science, engineering industries and consumer electronics markets, was today notified that David Deacon, Chief Financial Officer of the Group, has today transferred 398,676 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company to his wife, Angela Mary Deacon, for nil consideration. Following the transfer, Mr Deacon's beneficial holding in OMG (including his wife's holding) remains unchanged at 850,661 Ordinary Shares, representing 0.70% of the Company's total voting rights.

For further information please contact:

 

OMG plc +44 (0) 1865 261800

Nick Bolton, CEO

David Deacon, CFO

 

FTI Consulting +44 (0) 20 3727 1000

Matt Dixon / Emma Appleton / Harry Staight

 

N+1 Singer (NOMAD to OMG) +44 (0) 20 7496 3000

Shaun Dobson / Jen Boorer

 

 

Notes to Editors

 

About OMG plc

 

OMG plc (Oxford Metrics Group. LSE: OMG) is a group of technology companies producing Computer Vision products and services for the entertainment, life science, engineering industries and consumer electronics markets.

The Group's technology is used globally to capture the movements of actors (for the movie industry), sportsmen and women (for video games or improving team performance), and children with cerebral palsy, rehab patients and animals (for medical, life science and research industries). The technology is also used for the management of highways and other forms of distributed infrastructure assets, such as lighting systems and other street furniture. Through this diverse offering the Group has earned its strong international reputation for precision from pixels and its unique expertise in imaging technology.

Founded in 1984, the Group is headquartered in Oxford, UK, and has two offices in the US and four in the UK. It has customers in over 50 countries and is a quoted company listed on AIM, a market operated by the London Stock Exchange. The Group trades through three subsidiaries: Vicon, the world's largest motion capture and movement analysis company, Yotta, a provider of software and services for infrastructure asset management and OMG Life, our IP licensing business, which is focused on unlocking latent value in OMG's IP.

The Group's global clients spanning the worlds of science, medicine, sport, engineering, gaming, film and broadcast include: major hospitals and research facilities such as Guy's Hospital, Nuffield Orthopedic Centre, Headley Court and Loughborough University, engineering industry leaders including: Ford Motor Company, BMW, Toyota and European Space Agency and in the entertainment sector; The Imaginarium, Sony, Industrial Light and Magic, Sega, Nintendo, UbiSoft, EA and Square Enix. In infrastructure asset management, clients include Highways England, East Sussex, Kent, Lancashire, Transport for London, UK Power Network, Cheshire East and West as well as many others.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFFDFEAFISELE
Date   Source Headline
1st Jul 20258:48 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 202511:45 amRNSHolding(s) in Company
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSInterim Results
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20255:12 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSNon-Executive Board Changes
2nd Jun 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20252:15 pmRNS-RInvestor Presentation
27th May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20253:08 pmRNSHolding(s) in Company
9th May 202511:34 amRNSGrant of FY25 LTIP Awards to PDMRs
9th May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTotal Voting Rights
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSH1 Trading Update and Board Change
24th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 202510:19 amRNSHolding(s) in Company
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.